Arugula Sciences is a clinical stage biotech company dedicated to the discovery, development, and commercialization of more effective, more precise and more widely applied therapeutics that realize the full potential of human cell and tissue based products to support and improve the natural healing process of the body in wound, musculoskeletal, pain management and disease applications. The company’s current leading asset, Signature Cord Prime™, is focused on the treatment of osteoarthritis of the knee.
